Metallic gold treatment reduces proliferation of inflammatory cells, increases expression of VEGF and FGF, and stimulates cell proliferation in the subventricular zone following experimental traumatic brain injury

Histology and Histopathology

Volumn 24, Issue 5, 2009, Pages 573-586

  Pedersen, Mie Østergaard ^a   Larsen, Agnete ^b   Pedersen, Dan Sonne ^a   Stoltenberg, Meredin ^b   Penkowa, Milena ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Dissolucytosis; Growth factor; Metallic gold; Regeneration; Traumatic brain injury

Indexed keywords

MUS;

CELL CYCLE PROTEIN; DNA BINDING PROTEIN; FIBROBLAST GROWTH FACTOR; GOLD; MCM7 PROTEIN, MOUSE; NUCLEAR PROTEIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ADULT STEM CELL; ANIMAL; ARTICLE; BRAIN INJURY; C57BL MOUSE; CELL MOTION; CELL PROLIFERATION; DRUG EFFECT; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; METABOLISM; MOUSE; NERVE CELL; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; PATHOLOGY;

ADULT STEM CELLS; ANIMALS; BRAIN INJURIES; CELL CYCLE PROTEINS; CELL MOVEMENT; CELL PROLIFERATION; DNA-BINDING PROTEINS; FEMALE; FIBROBLAST GROWTH FACTORS; GOLD; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICE; MICE, INBRED C57BL; NERVE REGENERATION; NEUROGENESIS; NEURONS; NUCLEAR PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 67149086920     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Agasse F., Nicoleau C., Petit J., Jaber M., Roger M., Benzakour O. and Coronas V. (2007). Evidence for a major role of endogenous fibroblast growth factor-2 in apoptotic cortex-induced subventricular zone cell proliferation. Eur. J. Neurosci. 26, 3036-3042.
2. Alvarez-Buylla A., García-Verdugo J.M. and Tramontin A.D. (2001). A unified hypothesis on the lineage of neural stem cells. Nat. Rev. Neurosci. 2, 287-293.
3. Azumi N. and Battifora H. (1987). The distribution of vimentin and keratin in epithelial and nonepithelial neoplasms. A comprehensive immunohistochemical study on formalin-and alcohol-fixed tumors. Am. J. Clin. Pathol. 88, 286-296.
4. Bot P.T., Hoefer I.E., Piek J.J. and Pasterkamp G. (2008). Hyaluronic acid: targeting immune modulatory components of the extracellular matrix in atherosclerosis. Curr. Med. Chem. 15, 786-791.
5. Bramlett H.M. and Dietrich W.D. (2004). Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J. Cereb. Blood Flow Metab. 24, 133-50.
6. Danscher G. (2002). In vivo liberation of gold ions from gold implants. Autometallographic tracing of gold in cells adjacent to metallic gold. J. Histochem. Cytochem. 117, 447-452.
7. Danscher G. and Stoltenberg M. (2006). Autometallography (AMG). Silver enhancement of quantum dots resulting from (1) metabolism of toxic metals in animals and humans, (2) in vivo, in vitro and immersion created zinc-sulphur/zinc-selenium nanocrystals, (3) metal ions liberated from metal implants and particles. Prog. Histochem. Cytochem. 41, 57-139.
8. Das S. and Basu A. (2008). Inflammation: A new candidate in modulating adult neurogenesis. J. Neurosci. Res. 86, 1199-208.
9. Eisler R. (2003). Chrysotherapy: a synoptic review. Inflamm. Res. 52, 487-501.
10. Ekdahl C.T., Claasen J.H., Bonde S., Kokaia Z. and Lindvall O. (2003) Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl. Acad. Sci. USA 100, 13632-13627.
11. Faulkner J.R., Herrmann J.E., Woo M.J., Tansey K.E., Doan N.B. and Sofroniew M.V. (2004). Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 24, 2143-2155.
12. Ferrara N., Houck K.A., Jakeman L.B., Winer J. and Leung D.W. (1991). The vascular endothelial growth factor family of polypeptides. J. Cell. Biochem. 47, 211-218.
13. Gage F.H. (2002). Mammalian neural stem cells. Science 287, 1433-1438.
14. Giralt M., Penkowa M., Lago N., Molinero A. and Hidalgo J. (2002). Metallothionein-1+2 protect the CNS after a focal brain injury. Exp. Neurol. 173, 114-128.
15. Griem P. and Gleichmann E. (1996). Gold antirheumatic drug: desired and adverse effects of Au(I) and Au(III) on the immune system. Z. Rheumatol. 55, 348-358.
16. Heyworth B.E., Lee J.H., Kim P.D., Lipton C.B., Strauch R.J. and Rosenwasser M.P. (2008). Hylan versus corticosteroid versus placebo for treatment of basal joint arthritis: a prospective, randomized, double-blinded clinical trial. J. Hand. Surg. (Am) 33, 40-48.
17. Hyder A.A., Wunderlich C.A., Puvanachandra P., Gururaj G. and Kobusingye O.C. (2007). The impact of traumatic brain injuries: A global perspective. NeuroRehabilitation 22, 341-353.
18. Ihrie R.A. and Alvarez-Buylla A. (2008). Cells in the astroglial lineage are neural stem cells. Cell Tissue Res. 331, 179-191.
19. Jin K., Zhu Y., Sun Y., Mao X.O., Xie L. and Greenberg D.A. (2002). Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc. Natl. Acad. Sci. USA 99, 11946-11950.
20. Kabir N., Chaturvedi K., Liu L.S. and Sarkar D.K. (2005) Transforming growth factor-beta3 increases gap-junctional communication among folliculostellate cells to release basic fibroblast growth factor. Endocrinology 146, 4054-4060.
21. Kilic E., Kilic U., Wang Y., Bassetti C.L., Marti H.H. and Hermann D.M. (2006). The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. FASEB J. 20, 1185-1187.
22. Laird M.D., Vender J.R. and Dhandapani K.M. (2008). Opposing roles for reactive astrocytes following traumatic brain injury. Neurosignals 16, 154-164.
23. Larsen A., Stoltenberg M. and Danscher G. (2007). In vitro liberation of charged gold atoms: autometallographic tracing of gold ions released by macrophages grown on metallic gold surfaces. Histochem. Cell Biol. 128, 1-6
24. Larsen A., Kolind K., Pedersen D.S., Doering P., Pedersen M.O., Danscher G., Penkowa M. and Stoltenberg M. (2008) Metallic gold reduce inflammation and increase regenerative responses in focal brain injury. Histochem. Cell Biol. 130, 681-692.
25. Lloyd E., Somera-Molina K., Van Eldik L.J., Watterson D.M. and Wainwright M.S. (2008) Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injury. J. Neuroinflamma. 5, 28.
26. Lucas S-M., Rothwell N.J. and Gibson R.M. (2006). The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147, 232-240.
27. Meng H., Zhang Z., Zhang R., Liu X., Wang L., Robin A.M. and Chopp M. (2006). Biphasic effects of exogenous VEGF on VEGF expression of adult neural progenitors. Neurosci. Lett. 393, 97-101.
28. Ming G-L. and Song H. (2005). Adult neurogenesis in the mammalian central nervous system. Annu. Rev. Neurosci. 28, 223-250.
29. Mocchetti I. and Wrathall J.R. (1995). Neurotrophic factors in central nervous system trauma. J. Neurotrauma 12, 853-870.
30. Monfils M.H., Driscoll I., Kamitakahara H., Wilson B., Flynn C., Teskey G.C., Kleim J.A. and Kolb B. (2006). FGF-2-induced cell proliferation stimulates anatomical, neurophysiological and functional recovery from neonatal motor cortex injury. Eur. J. Neurosci. 24, 739-749.
31. Morgan R., Kreipke C.W., Roberts G., Bagchi M. and Rafols J.A. (2007). Neovascularization following traumatic brain injury: possible evidence for both angiogenesis and vasculogenesis. Neurol. Res. 29, 375-381.
32. Nagashima M., Yoshino S., Aono H., Takai M. and Sasano M. (1999). Inhibitory effects of anti-rheumatic drugs on vascular endothelial growth factor in cultured rheumatoid synovial cells. Clin. Exp. Immunol. 116, 360-365.
33. Nagashima M., Wauke K., Hirano D., Ishigami S., Aono H., Takai M., Sasano M. and Yoshino S. (2000). Effects of combinations of antirheumatic drugs on the production of vascular endothelial growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arthritis. Rheumatology (Oxford) 39, 1255-1262.
34. Nakagawa T., Yabe T. and Schwartz J.P. (2005). Gene expression profiles of reactive astrocytes cultured from dopamine-depleted striatum. Neurobiol. Dis. 20, 275-82.
35. Paxinos G. and Franklin K.B.J. (1997). The mouse brain in stereotaxic coordinates. 2nd edition. Elsevier Science. USA.
36. Penkowa M. (2006). Metallothionein I + II expression and roles during neuropathology in the CNS. Dan. Med. Bull. 53, 105-121.
37. Penkowa M., Giralt M., Moos T., Thomsen P.S., Hernandez J. and Hidalgo J. (1999a). Impaired inflammatory response to glial cell death in genetically metallothionein-I-and-II-deficient mice. Exp. Neurol. 156, 149-164.
38. Penkowa M., Carrasco J., Giralt M., Moos T. and Hidalgo J. (1999b). CNS wound healing is severely depressed in metallothionein I-and II-deficient mice. J. Neurosci. 19, 2535-2545.
39. Penkowa M., Moos T., Carrasco J., Hadberg H., Molinero A., Bluethmann H. and Hidalgo J. (1999c). Strongly compromised inflammatory response to brain injury in Interleukin-6-deficient mice. Glia 25, 343-57.
40. Penkowa M., Giralt M., Carrasco J., Hadberg H. and Hidalgo J. (2000). Impaired inflammatory response and increased oxidative stress and neurodegeneration after brain injury in interleukin-6-deficient mice. Glia 32, 271-285.
41. Penkowa M., Giralt M., Lago N., Camats J., Carrasco J., Hernández J., Molinero A., Campbell I.L. and Hidalgo J. (2003). Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury. Exp. Neurol. 181, 130-148.
42. Quintana A., Giralt M., Rojas S., Penkowa M., Campbell I.L., Hidalgo J. and Molinero A. (2005). Differential role of tumor necrosis factor receptors in mouse brain inflammatory responses in cryolesion brain injury. J. Neurosci. Res. 82, 701-716.
43. Rifkin D.B. and Moscatelli D. (1989). Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol. 109, 1-6.
44. Schiff M.H. and Whelton A. (2000). Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis. Semin. Arthritis Rheum. 30, 196-208.
45. Schouten J.W. (2007). Neuroprotection in traumatic brain injury: a complex struggle against the biology of nature. Curr. Opin. Crit. Care 13, 134-142.
46. Schänzer A., Wachs F.P., Wilhelm D., Acker T., Cooper-Kuhn C., Beck H., Winkler J., Aigner L., Plate K.H. and Kuhn H.G. (2004). Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor. Brain Pathol. 14, 237-248.
47. Shen Q., Goderie S.K., Jin L., Karanth N., Sun Y., Abramova N., Vincent P., Pumiglia K. and Temple S. (2004). Endothelial cells stimulate selfrenewal and expand neurogenesis of neural stem cells. Science 304, 1338-1340.
48. Simard A.R. and Rivest S. (2004). Role of inflammation in the neurobiology of stem cells. Neuroreport 15, 2305-2310.
49. Sofroniew M.V. (2005). Reactive astrocytes in neural repair and protection. Neuroscientist 11, 400-407.
50. Sun Y., Shi J. and Lu P.H. (2002). Neurotrophic factors and neural stem cells. Sheng. Li. Ke. Xue. Jin. Zhan. 33, 313-316.
51. Suzuki S., Adachi A., Hiraiwa A., Ohashi M., Ishibashi M. and Kiyono T. (1998). Cloning and characterization of human MCM7 promoter. Gene 216, 85-91.
52. Tehranian R., Andell-Jonsson S., Beni S., Yatsiv I., Shohami E., Bartfai T., Lundkvist J. and Iverfeldt K. (2002) Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted form of the interleukin receptor antagonist. J. Neurotrauma. 19, 939-951.
53. Thibeault S.L. and Duflo S. (2008). Inflammatory cytokine responses to synthetic extracellular matrix injection to the vocal fold lamina propria. Ann. Otol. Rhinol. Laryngol. 117, 221-226.
54. Traber K.E., Okamotot H., Kurono C., Baba M., Saliou C., Soji T., Packer L. and Okamoto T. (1999). Anti-rheumatic compound aurothioglucose inhibits tumor necrosis factor--induced HIV-1 replication in latently infected OM10.1 and Ach2 cells. Int. Immunol. 11, 143-150.
55. Toulmond S. and Rothwell N. (1995) Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat. Brain Res. 671, 261-266.
56. Werner C. and Engelhard K. (2007). Pathophysiology of traumatic brain injury. Br. J. Anaesth. 99, 4-9.
57. Xiao Z., Kong Y., Yang S., Li M., Wen J. and Li L. (2007). Upregulation of Flk-1 by bFGF via the ERK pathway is essential for VEGFmediated promotion of neural stem cell proliferation. Cell. Res. 17, 73-79.
58. Yanni G., Nabil N., Farahat M.R., Poston R.N. and Panayi G.S. (1994). Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane. Ann. Rheum. Dis. 53, 315-322.
59. Yoshida S-I., Kato T., Sakurada S., Kurono C., Yang J-P., Matsui N., Soji T. and Okamato T. (1999). Inhibition of IL-6 and IL-8 induction from cultured rheumatoid synovial fibroblasts by treatment with aurothioglucose. Int. Immunol. 11, 151-158.
60. Zachary I. (2005). Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential. Neurosignals 14, 207-221.
61. Zhang C.X. and Lippard S.J. (2003). New metal complexes as potential therapeutics. Curr. Opin. Chem. Biol. 7, 481-489.
62. Zhang H., Vutskits L., Pepper M.S. and Kiss J.Z. (2003). VEGF is a chemoattractant for FGF-2-stimulated neural progenitors. J. Cell Biol. 163, 1375-1384.